Parameter | Total, n | (%) |
---|---|---|
Age at diagnosis | Â | Â |
   Median (range) | 50 years | (24-83) |
Tumor size | Â | Â |
   ≤ 2 cm | 77 | (41) |
   > 2 cm | 110 | (59) |
Nodal status | Â | Â |
   Negative | 71 | (41) |
   Positive | 101 | (59) |
Tumor grade | Â | Â |
   1 | 31 | (17) |
   2 | 87 | (46) |
   3 | 69 | (37) |
Histologic tumor type | Â | Â |
   IDC (NOS) | 150 | (80) |
   Other histologic type | 37 | (20) |
PVI | Â | Â |
   Absent | 114 | (66) |
   Present | 59 | (34) |
NPI | Â | Â |
   Good (≤ 3.4) | 49 | (26) |
   Moderate (3.4-5.4) | 88 | (47) |
   Poor (> 5.4) | 50 | (27) |
ER status | Â | Â |
   Negative (≤ 10%) | 53 | (29) |
   Positive (> 10%) | 131 | (71) |
PR status | Â | Â |
   Negative (≤ 10%) | 76 | (42) |
   Positive (> 10%) | 107 | (58) |
MIB1 | Â | Â |
   Negative (≤ 20%) | 79 | (43) |
   Positive (> 20%) | 104 | (57) |
HER2 status | Â | Â |
   Negative | 133 | (85) |
   Positive | 23 | (15) |
Cytoplasmic NHERF1 | Â | Â |
   Negative (≤ 40%) | 105 | (69) |
   Positive (> 40%) | 47 | (31) |
Membranous NHERF1 | Â | Â |
   Negative (0%) | 134 | (87) |
   Positive (> 0%) | 20 | (13) |
VEGFR1 | Â | Â |
   Negative (≤ 2%) | 82 | (50) |
   Positive (> 2%) | 82 | (50) |
HIF-1α |  |  |
   Negative (0%) | 98 | (63) |
   Positive (> 0%) | 58 | (37) |
TWIST1 | Â | Â |
   Negative (≤ 3%) | 69 | (49) |
   Positive (> 3%) | 73 | (51) |